Antiarrhythmic drugs Flashcards

1
Q

What is the electrophysiology involved in the heart?

A

The myocardium is electrophysiologically distinct from other excitable tissues:

 The specialized cells of the SA node are capable of
spontaneous depolarization (automaticity) and
generation of action potentials (AP) that spread
throughout the heart (“pacemaker” activity).

 The generation and conduction of AP in SA and AV is
mainly dependent on slow Ca++ ion channels.
Absence of fast Na+ currents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the different phases of the action potential?

A

 Phase 0: rapid depolarization
- The rapid influx of Na+ through voltage-gated ion channels

 Phase 1: Rapid initial repolarization
- Rapid inactivation of the sodium channels

 Phase 2: Plateau
- The influx of Ca++ through the slow Ltype ion channel

 Phase 3: Repolarization
- Efflux of K+ from the cells

 Phase 4: Spontaneous diastolic depolarization

  • Slow Na+ channels
  • Influx of Ca++ through the slow Ltype ion channel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the action potential in the SA node?

A
 Phase 4: Spontaneous diastolic
depolarization:
 Opening of slow Na+ channels -
"funny" currents: initiation of
depolarization
 -50mV opening of T-type Ca
channels: continuation of
depolarization
 -40 mV opening of L-type Ca
channels: continuation of
depolarization
 Phase 0: Depolarization (at
-35mV)
 Mainly caused by the influx of Ca2+
through L-тип Ca2+ канали
 The current through these channels
is slow and that is why the
depolarization is slower than in other
cardiac cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the types of action potentials in the heart?

A

Two types of AP based
on the mechanism of
depolarization:

 Dependent on “slow”
Ca++ channels (L type):
 SA node
 AV node

 Dependent on “rapid”
Na+ channels:
 Atria
 His-Purkinje fibers
 Ventricles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are cardiac arrhythmias?

A

 Clinically, arrhythmias are classified
according to:

- The site of their origin –
supraventricular (atrial, junctional) and
ventricular
- Whether the heart rate is increased
(tachycardia) or decreased
(bradycardia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the causes of arrhythmias?

A

 Changes in the
pacemaker activity of SA
node

 Block in the conduction of
impulses

 Ectopic foci, causing
abnormal AP favored by
 Digitalis excess
 Catecholamines
 Ischemia
 Electrolite disbalance
 Drug toxicity

 Re-entry mechanism
(“circus movement”)
 Abnormal conductance
(WPW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are antiarrhythmic drugs classified? (Vaughan William’s classification)

A
Class I (sodium channel-blocking drugs)
 IA: Prolongation of repolarization
 Quinidine
 IB: Shortening of repolarization
 Lidocaine
 Phenytoin
 IC: No effect on repolarization
 Propafenone
 Class II (BABs)
 Propranolol, Metoprolol, etc.

Class III (drugs prolonging the AP) – Block K+
outward currents
 Amiodarone, Sotalol

Class IV (Non-DHP type CCBs)
 Verapamil, Diltiazem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Na+ channel states?

A

resting -> activated -> inactivated

Na+ channel block:

Higher affinity of the drugs to activated and inactivated than to resting states of the channels -> selective action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is an example of a class IA antiarrhythmic drug? what are its clinical uses?

A

Effect of Class I on the fast cardiac action potential =
Slope of phase 0

 Quinidine
 Binds to Na+ channels; intermediate dissociation from the
channels
 Prolongs repolarization due to a certain blockade of K+
channels

Clinical use:

 Ventricular arrhythmias
 Prevention of recurrent paroxysmal atrial fibrillation
triggered by vagal overactivity
 It is now seldom used because of side effects:
 Cardiac, incl. pro-arrhythmic (QRS)
 Anti-cholinergic
 GI
 Allergic
 CNS – ‘cinchonism’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an example of a class IB antiarrhythmic drug and what are its PK, PD, clinical use, and tolerability?

A

Lidocaine: the most widely used class I AAD

 PK:
 Significant first-pass metabolism
 Only given by IV bolus or infusion
 Plasma half-life ~ 2 hrs

 PD:
 Binds to Na+ channels in the open and inactivated states;
shows fast dissociation from the channels
 Only marginally affects conduction velocity; shortens AP
duration
 Effective in aborting ventricular ectopic beats, especially
in ischemia

 Clinical use: i.v. ventricular tachycardia in acute
myocardial infarction (AMI).

 Tolerability profile: safe
 CNS: drowsiness, disorientation, convulsions
 Low pro-arrhythmic potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is an example of a class IC antiarrhythmic drug and what are its uses?

A

 Propafenone

 Binds to Na+ channels
 Does not influence AP duration

 Used in:
 supraventricular arrhythmias (paroxismal atrial
fibrillation)
 recurrent tachyarrhythmias associated with abnormal
conducting pathways (e.g. Wolff-Parkinson-White
syndrome).

 Side effects:
 Меtal taste, constipation
 Cardiac: pro-arrhythmic (QRS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drugs affect the pacemaker activity?

A

β agonist

M-agonist, BAB, Adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some clinical uses of class II AADs?

A

Class II AADs (propranolol, metoprolol)
reduce mortality in patients recovering
from myocardial infarction, and should
always be considered in this setting.

 Used for prophylaxis against recurrent
tachyarrhythmias (e.g. paroxismal atrial
fibrillation) when these are provoked by
increased sympathetic activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the effect of potassium channel blockers?

A

Prolong AP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an example of class III AADs? (chemical nature, PK considerations, electrophysiology and PD effects, ADRs) - Amiodarone

A

Amiodarone

 Chemical nature:
 Contains iodine in its molecule

 PK considerations:
 May be given orally or IV (loading dose)
 Extensively bound to tissue proteins → large Vd and a long t1/2 (10-100
days), therefore slowly established steady state concentration

 Electrophysiological and PD effects
 Blocks K+ outward currents
 Prolongation of the AP and effective RP
 Some beta-adrenoblocking activity

ADRs:
Short term:
- Bradycardia
- AV block
- Hypotension

Long-term:

  • Thyroid abnormalities
  • pulmonary fibrosis
  • corneal deposits and optic neuropathy
  • photosensitivity

Therapeutic uses: highly effective in a wide variety of ventricular and
supraventricular arrhythmias

 Despite the significant prolongation of QT, ‘torsade de pointes’ syndrome is relatively seldom seen in clinics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is sotalol?

A

Sotalol – combines class III with class II actions and adverse effects.

 It is used in paroxysmal supraventricular
arrhythmias.
 It suppresses ventricular ectopic beats and
short runs of ventricular tachycardia.
 It can cause ‘torsade de pointes’ and is
contraindicated in patients with asthma or
other contraindications to beta-blockade.

17
Q

What is the effect of calcium channel blockers?

A

Slope of phase 0

18
Q

What are the clinical uses of class IV AADs?

A

Non-DHP

 Verapamil is the main drug.
 Diltiazem is similar.

 They are used:

 To prevent recurrence of paroxysmal supraventricular
tachycardia

 To reduce ventricular rate in patients with atrial fibrillation
(especially if inadequately controlled with digoxin)

 They are ineffective in ventricular arrhythmias.

19
Q

What are some examples of antiarrhythmic drugs that are unclassified in Vaughan William’s system?

A

Atropine – Sinus bradycardia

 Digoxin – Atrial fibrillation

 Epinephrine – Cardiac arrest

 Adenosine – Supraventricular tachycardia

 PK: t1/2 10 sec. (it is taken up via a specific nucleoside transporter by red blood
cells and is metabolised by enzymes on the lumenal surface of vascular
endothelium. Consequently, the effects of a bolus dose of adenosine last only 20-
30 s.)

 PD:
 A1 receptor (AV node) – linked to the same cardiac potassium channel
 Hyperpolarises cardiac conducting tissue and slows the rate of rise of the
pacemaker potential
 Inhibition of AV conductance and weaker effect in the SA node

 Clinical use:
 Administered intravenously to terminate SVT

 Unwanted effects:
 Chest pain
 Shortness of breath
 Dizziness
 Nausea